Studies show that in patients with MS, the population of subcellular Th17 cells and consequently the expression level of the IL17 gene are increased in PBMC, cerebrospinal fluid (CSF) and brain lesions or MS plaques, especially in the relapse phase compared to the recovery phase.34, 35. Here, IL17A is linked to myeloid sarcoma.